Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial.
Petrylak DP, Ratta R, Matsubara N, Korbenfeld E, Gafanov R, Mourey L, Todenhöfer T, Gurney H, Kramer G, Bergman AM, Zalewski P, De Santis M, Armstrong AJ, Gerritsen W, Pachynski R, Byun SS, Retz M, Levesque E, McDermott R, Bracarda S, Manneh R, Levartovsky M, Li XT, Schloss C, Poehlein CH, Fizazi K.
Petrylak DP, et al. Among authors: todenhofer t.
J Clin Oncol. 2025 May 10;43(14):1638-1649. doi: 10.1200/JCO-24-01283. Epub 2025 Mar 5.
J Clin Oncol. 2025.
PMID: 40043230
Free PMC article.
Clinical Trial.